157 related articles for article (PubMed ID: 38538728)
1. Methylation analysis of DCC gene in saliva samples is an efficient method for non-invasive detection of superficial hypopharyngeal cancer.
Hirai R; Kinugasa H; Yamamoto S; Ako S; Tsutsumi K; Abe M; Miyahara K; Nakagawa M; Otsuka M
Br J Cancer; 2024 Jun; 130(10):1725-1731. PubMed ID: 38538728
[TBL] [Abstract][Full Text] [Related]
2. EDNRB and DCC salivary rinse hypermethylation has a similar performance as expert clinical examination in discrimination of oral cancer/dysplasia versus benign lesions.
Schussel J; Zhou XC; Zhang Z; Pattani K; Bermudez F; Jean-Charles G; McCaffrey T; Padhya T; Phelan J; Spivakovsky S; Brait M; Li R; Bowne HY; Goldberg JD; Rolnitzky L; Robbins M; Kerr AR; Sirois D; Califano JA
Clin Cancer Res; 2013 Jun; 19(12):3268-75. PubMed ID: 23637120
[TBL] [Abstract][Full Text] [Related]
3. Validation of methylation markers for diagnosis of oral cavity cancer.
Arantes LM; de Carvalho AC; Melendez ME; Centrone CC; Góis-Filho JF; Toporcov TN; Caly DN; Tajara EH; Goloni-Bertollo EM; Carvalho AL;
Eur J Cancer; 2015 Mar; 51(5):632-41. PubMed ID: 25686481
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation in Indian primary oral squamous cell carcinoma.
Kaur J; Demokan S; Tripathi SC; Macha MA; Begum S; Califano JA; Ralhan R
Int J Cancer; 2010 Nov; 127(10):2367-73. PubMed ID: 20473870
[TBL] [Abstract][Full Text] [Related]
5. Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy.
Pattani KM; Zhang Z; Demokan S; Glazer C; Loyo M; Goodman S; Sidransky D; Bermudez F; Jean-Charles G; McCaffrey T; Padhya T; Phelan J; Spivakovsky S; Bowne HY; Goldberg JD; Rolnitzky L; Robbins M; Kerr AR; Sirois D; Califano JA
Cancer Prev Res (Phila); 2010 Sep; 3(9):1093-103. PubMed ID: 20798208
[TBL] [Abstract][Full Text] [Related]
6. Aberrant DNA methylation of tumor-related genes in oral rinse: a noninvasive method for detection of oral squamous cell carcinoma.
Nagata S; Hamada T; Yamada N; Yokoyama S; Kitamoto S; Kanmura Y; Nomura M; Kamikawa Y; Yonezawa S; Sugihara K
Cancer; 2012 Sep; 118(17):4298-308. PubMed ID: 22252571
[TBL] [Abstract][Full Text] [Related]
7. KIF1A and EDNRB are differentially methylated in primary HNSCC and salivary rinses.
Demokan S; Chang X; Chuang A; Mydlarz WK; Kaur J; Huang P; Khan Z; Khan T; Ostrow KL; Brait M; Hoque MO; Liegeois NJ; Sidransky D; Koch W; Califano JA
Int J Cancer; 2010 Nov; 127(10):2351-9. PubMed ID: 20162572
[TBL] [Abstract][Full Text] [Related]
8. Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum.
Hulbert A; Jusue-Torres I; Stark A; Chen C; Rodgers K; Lee B; Griffin C; Yang A; Huang P; Wrangle J; Belinsky SA; Wang TH; Yang SC; Baylin SB; Brock MV; Herman JG
Clin Cancer Res; 2017 Apr; 23(8):1998-2005. PubMed ID: 27729459
[No Abstract] [Full Text] [Related]
9. Comparison of promoter hypermethylation pattern in salivary rinses collected with and without an exfoliating brush from patients with HNSCC.
Sun W; Zaboli D; Liu Y; Arnaoutakis D; Khan T; Wang H; Koch W; Khan Z; Califano JA
PLoS One; 2012; 7(3):e33642. PubMed ID: 22438973
[TBL] [Abstract][Full Text] [Related]
10. The value of endothelin receptor type B promoter methylation as a biomarker for the risk assessment and diagnosis of prostate cancer: A meta-analysis.
Yuan Y; Du Y; Wang L; Liu X
Pathol Res Pract; 2020 Feb; 216(2):152796. PubMed ID: 31926772
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylated EDNRB can act as a potential diagnostic biomarker in sporadic colorectal cancer while KISS1 is controversial.
Mousavi Ardehaie R; Hashemzadeh S; Behrouz Sharif S; Ghojazadeh M; Teimoori-Toolabi L; Sakhinia E
Bioengineered; 2017 Sep; 8(5):555-564. PubMed ID: 28140749
[TBL] [Abstract][Full Text] [Related]
12. Clinical correlates of promoter hypermethylation of four target genes in head and neck cancer: a cooperative group correlative study.
Roh JL; Wang XV; Manola J; Sidransky D; Forastiere AA; Koch WM
Clin Cancer Res; 2013 May; 19(9):2528-40. PubMed ID: 23444219
[TBL] [Abstract][Full Text] [Related]
13. Methylated genomic loci encoding microRNA as a biomarker panel in tissue and saliva for head and neck squamous cell carcinoma.
Cao Y; Green K; Quattlebaum S; Milam B; Lu L; Gao D; He H; Li N; Gao L; Hall F; Whinery M; Handley E; Ma Y; Xu T; Jin F; Xiao J; Wei M; Smith D; Bornstein S; Gross N; Pyeon D; Song J; Lu SL
Clin Epigenetics; 2018; 10():43. PubMed ID: 29636832
[TBL] [Abstract][Full Text] [Related]
14. Aberrant methylation of the netrin-1 receptor genes UNC5C and DCC detected in advanced colorectal cancer.
Hibi K; Mizukami H; Shirahata A; Goto T; Sakata M; Sanada Y
World J Surg; 2009 May; 33(5):1053-7. PubMed ID: 19242752
[TBL] [Abstract][Full Text] [Related]
15. Expression of protocadherin8: Function as a tumor suppressor in hypopharyngeal carcinoma.
Li Y; Liu C; Wang Z; Hu G
Cancer Biomark; 2018; 22(3):495-502. PubMed ID: 29865037
[TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer.
Roperch JP; Incitti R; Forbin S; Bard F; Mansour H; Mesli F; Baumgaertner I; Brunetti F; Sobhani I
BMC Cancer; 2013 Dec; 13():566. PubMed ID: 24289328
[TBL] [Abstract][Full Text] [Related]
17. Aberrant GRK6 promoter methylation is associated with poor prognosis in hypopharyngeal squamous cell carcinoma.
Qiu X; Chen J; Zhang Z; You Y; Wang Z
Oncol Rep; 2016 Feb; 35(2):1027-33. PubMed ID: 26718636
[TBL] [Abstract][Full Text] [Related]
18. DCC promoter hypermethylation in esophageal squamous cell carcinoma.
Park HL; Kim MS; Yamashita K; Westra W; Carvalho AL; Lee J; Jiang WW; Baek JH; Liu J; Osada M; Moon CS; Califano JA; Mori M; Sidransky D
Int J Cancer; 2008 Jun; 122(11):2498-502. PubMed ID: 18302152
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive detection of endometrial cancer by DNA methylation analysis in urine.
van den Helder R; Wever BMM; van Trommel NE; van Splunter AP; Mom CH; Kasius JC; Bleeker MCG; Steenbergen RDM
Clin Epigenetics; 2020 Nov; 12(1):165. PubMed ID: 33143739
[TBL] [Abstract][Full Text] [Related]
20. Aberrant promoter methylation of EDNRB in lung cancer in Taiwan.
Chen SC; Lin CY; Chen YH; Fang HY; Cheng CY; Chang CW; Chen RA; Tai HL; Lee CH; Chou MC; Lin TS; Hsu LS
Oncol Rep; 2006 Jan; 15(1):167-72. PubMed ID: 16328051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]